Two PI firms. Same monthly ad spend. Same mix of lead vendors. One finishes the quarter with 40 signed cases; the other finishes with 28. The difference almost never comes down to budget size or agency talent — it comes down to how each firm actually uses its marketing data, and what decisions that data drives.
The gap is behavioral and structural, not technological. Top-performing firms have built specific habits around how data is collected, reviewed, and acted on. (For the full strategic framework these firms build on, see our personal injury marketing guide.) This article maps those habits specifically.
| Practice | Average Firms | Top Performers | |
|---|---|---|---|
| Primary Metric | Cost per lead | Cost per signed case | |
| Data Connection | Marketing and intake separate | Marketing connected to intake | |
| Review Cadence | Monthly | Weekly operational + monthly strategic | |
| Vendor Conversations | Use vendor-provided reports | Use first-party data | |
| Historical Data | Build when needed | Build before needed | |
| Partner Reporting | Activity metrics | ROI and cost per case | |
| Underperformance Response | Cut the vendor | Diagnose first, then act |
They Measure Outcomes, Not Just Activity
Most PI firms run an activity-first view of marketing: leads generated, clicks, impressions, cost per lead. They know how much marketing activity is happening. They don't know what that activity is producing at the case level.
Top-performing firms flip the metric hierarchy. Cost per signed case is their primary number. Everything else — CPL, contact rate, conversion rate — is a diagnostic tool for understanding why that number is where it is, and how to move it.
This distinction changes which conversations happen. A firm measuring CPL notices when a vendor gets more expensive per lead. A firm measuring cost per case notices when CPL rises and conversion drops simultaneously — meaning the real cost per case jumped far more than either metric alone suggested. That firm has a sharper, earlier signal and a stronger basis for action.
They Connect Marketing Data to Intake Data
Keep reading
In most PI firms, marketing and intake run as separate operations with separate data environments. Marketing tracks leads. Intake tracks cases. The link between them is informal — often dependent on one person's knowledge, never systematic.
Top-performing firms build the connection explicitly. Every lead in their intake system carries a vendor source tag. Every signed case retains that tag. Every monthly report can therefore answer: which vendors produced signed cases, at what conversion rate, and at what cost per case? This isn't technically complex — it takes a data convention and the discipline to enforce it across the intake team.
The payoff is speed. When a vendor's conversion rate starts declining, the marketing director sees it in intake data before it becomes a budget problem. When a new vendor launches, real performance is visible within 60 days. Without that connection, neither signal exists.
They Review Data Weekly, Not Monthly
Monthly reporting is standard in PI marketing. Top-performing firms supplement it with weekly operational reviews — shorter, faster, focused on current-week data against a 4-week moving average.
The weekly review isn't a full meeting. It's a 15-minute scan: lead volume by vendor versus trailing average, intake contact rate, pacing against the monthly signed-case goal. That's enough to surface anomalies while there's still time to act.
A vendor down 30% in lead volume on Tuesday is a problem you can address Thursday. The same signal in a monthly report is already three weeks stale — and the cases missed in that window are permanently gone. Weekly reviews are the operational infrastructure that makes real-time decisions possible.
They Use First-Party Data in Vendor Conversations
Most firms negotiate with lead vendors using the vendor's own reports. The vendor is naturally positioned to defend those numbers.
Top-performing firms bring their own data: their intake system's record of lead volume, contact rate, conversion rate, and cost per signed case for that vendor. When the numbers diverge — and they regularly do — the firm's data carries more weight because it reflects what actually happened at intake.
This reshapes the conversation entirely. You're no longer debating impressions about lead quality against a vendor's dashboard. You're presenting documented performance against defined benchmarks. Vendors respond differently. Conversations are faster, more specific, and more likely to produce real changes.
They Build Historical Data Even Before They Need It
The most valuable data a PI marketing director can hold is 24 months of connected vendor, intake, and settlement records. That data takes 24 months to build. Firms that start now have it in two years. Firms that wait until they need it never do.
Top-performing firms invest in data infrastructure before the payoff is visible. They enforce lead source tagging even when it adds friction. They record case severity at intake even when most cases are still open. They connect marketing spend records to their case management system before settlement data is available to close the loop.
The compounding effect is real. A firm with 18 months of clean attribution data can answer questions that a firm with 6 months cannot. A firm with vendor-level settlement attribution makes budget decisions that competitors are guessing at. That advantage builds month by month — and it belongs entirely to whoever starts first.
They Share Downstream Data With Their Agency
Most PI firms treat intake conversion data as internal-only. Top-performing firms share it deliberately — conversion rates, rejection reasons, case quality feedback — with their marketing agencies and lead vendors.
The logic is simple. Your agency can only optimize what they can see. If a targeting approach generates leads that fail intake screening at high rates, they need that feedback to adjust. If one ad campaign produces leads that convert at twice the rate of another, they need that signal to shift spend toward what works.
Sharing downstream data isn't a vulnerability — it's how you make your agency sharper. The best agency performance happens when agencies have the fullest picture of what happens after a lead arrives. That picture only exists if you give it to them.
They Present ROI, Not Activity, to Partners
In the average partner meeting, the marketing director presents activity: leads generated, cases signed, spend for the period. Managing partners receive this and ask the follow-up question that usually doesn't get a clean answer: “What's the return on that investment?”
Top-performing marketing leaders answer that question before it's asked. They walk into the partner meeting with cost per case by vendor, a comparison to benchmark, a 6-month trend, and a projected ROI based on average settlement values for cases signed. They lead with the answer, not the activity.
That shift changes the partner dynamic. Managing partners who see a clear ROI narrative have fewer concerns about the marketing budget. They ask better questions. The conversation moves from “justify your spend” to “how do we scale what's working?” The data doesn't just inform the conversation — it changes what the conversation is about.
They Treat Underperformance as a Diagnostic Problem
When a vendor underperforms, the default response is to cut them. Top-performing firms diagnose first. Is the problem lead quality or intake execution? Is a declining conversion rate isolated to one geography or case type? Is the cost-per-case increase driven by higher CPL, lower conversion, or both?
Diagnosing before acting prevents costly mistakes. A vendor whose conversion rate dropped because your intake team changed their call schedule — not because lead quality declined — looks like a bad vendor in the data until you correct the intake variable. Cutting that vendor is expensive: you lose a source that was performing, and you replace it with something new that carries its own ramp-up and its own uncertainty.
The discipline of diagnosing before acting is one of the clearest differentiators between sophisticated PI marketing operations and the rest. Data drives the hypothesis. Investigation confirms or refutes it. Only then does action follow.